53 related articles for article (PubMed ID: 36409821)
1. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
[TBL] [Abstract][Full Text] [Related]
2. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract][Full Text] [Related]
4. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract][Full Text] [Related]
5. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
[TBL] [Abstract][Full Text] [Related]
8.
Mubeen A; Parra-Herran C
J Clin Pathol; 2023 Dec; 76(12):798-801. PubMed ID: 37798106
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.
Alexiadis M; Chu S; Leung D; Gould JA; Jobling T; Fuller PJ
Oncotarget; 2016 Mar; 7(12):14207-19. PubMed ID: 26893359
[TBL] [Abstract][Full Text] [Related]
10. Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup.
Roze J; Monroe G; Kutzera J; Groeneweg J; Stelloo E; Paijens S; Nijman H; Meurs HV; Lonkhuijzen LV; Piek J; Lok C; Jonges G; Witteveen P; Verheijen R; Haaften GV; Zweemer R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455687
[TBL] [Abstract][Full Text] [Related]
11. Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.
Nagy A; Niu N; Ratner E; Hui P; Buza N
Int J Gynecol Pathol; 2024 Feb; ():. PubMed ID: 38426544
[TBL] [Abstract][Full Text] [Related]
12. Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.
Dahoud W; Handler J; Parimi V; Meyer CF; Wethington SL; Eshleman JR; Vang R; Ronnett BM; Xing D
Int J Gynecol Pathol; 2022 Nov; 41(6):600-607. PubMed ID: 34856571
[TBL] [Abstract][Full Text] [Related]
13. Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis.
Gao Y; Vincent DF; Davis AJ; Sansom OJ; Bartholin L; Li Q
Oncotarget; 2016 Jul; 7(27):40904-40918. PubMed ID: 27344183
[TBL] [Abstract][Full Text] [Related]
14. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence.
Liu Y; Chen J; Lu Z; Chang X; Wang P; Ma H; Chen X; Mo S; Lv Z; Mao X; Zong L; Yu S; Chen J
Gynecol Oncol; 2023 Sep; 176():106-114. PubMed ID: 37481922
[TBL] [Abstract][Full Text] [Related]
16. The forkhead DNA-binding domain binds specific G2-rich RNA sequences.
Zutterling C; Todeschini AL; Fourmy D; Busso D; Veaute X; Ducongé F; Veitia RA
Nucleic Acids Res; 2023 Dec; 51(22):12367-12380. PubMed ID: 37933840
[TBL] [Abstract][Full Text] [Related]
17. Metabolic characteristics of granulosa cell tumor: role of PPARγ signaling†.
Yu SY; Luan Y; Xu PC; Zhang Y; Dong R; Abazarikia A; Kim SY
Biol Reprod; 2024 Mar; 110(3):509-520. PubMed ID: 38123510
[TBL] [Abstract][Full Text] [Related]
18. Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.
Khlebus E; Vuttaradhi VK; Welte T; Khurana N; Celestino J; Beird HC; Gumbs C; Little L; Legarreta AF; Fellman BM; Nguyen T; Lawson B; Ferri-Borgogno S; Mok SC; Broaddus RR; Gershenson DM; Futreal PA; Hillman RT
Mol Cancer Res; 2023 May; 21(5):483-494. PubMed ID: 37068116
[TBL] [Abstract][Full Text] [Related]
19. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL
Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
